Search
forResearch 10 of 1000+
- Patient-Reported Outcomes From Phase III Neoadjuvant Systemic Trial Comparing Neoadjuvant Chemotherapy With Neoadjuvant Endocrine Therapy in Pre-Menopausal Patients With Estrogen Receptor-Positive and HER2-Negative, Lymph Node-Positive Breast Cancer
- Impact of systemic hormonal imbalances on sebaceous gland disorders: An in-depth review integrating clinical, endocrine, and therapeutic insights
- Response to Javaheri et al., “Topical estrogens: Use in hair loss and additional safety concerns for consideration”
- MANAGING ESTROGEN-DEFICIENT SKIN: A NARRATIVE REVIEW ON THE ROLE OF HRT AND EMERGING ESTROGEN-MODULATING THERAPIES
- Hormone-related hair disorders - from clinical needs to new therapeutic perspectives
- Acne and Systemic Disease
- The Safety of Local Hormonal Treatment for Vulvovaginal Atrophy in Women With Estrogen Receptor-positive Breast Cancer Who Are on Adjuvant Aromatase Inhibitor Therapy: Meta-analysis
- Endocrine Aspects of Female Sexual Dysfunction
- Human skin
- SAT-214 Satoyoshi Syndrome: A Rare Cause of Premature Ovarian Failure
Community 3 of 164
- Is it possible to create an estrogen mesotherapy/topical that doesn't go systemic?
- Hypothetically, if estradiol has been a "cure" for hair loss, could one apply estradiol topically and just take an estrogen blocker and/or testosterone to offset the systematic effects?
- Anyone try Ell-Cranell or Eucapil?
Learn
— no results
Try a deeper search in learn →